Citadel Advisors - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is and the CUSIP is 14888U901. A total of 2 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$3,000
-72.7%
1,300
-63.9%
0.00%
Q3 2015$11,000
+120.0%
3,600
+200.0%
0.00%
Q2 2015$5,000
-37.5%
1,200
-36.8%
0.00%
Q1 2015$8,000
+166.7%
1,900
+72.7%
0.00%
Q4 2014$3,000
-90.0%
1,100
-87.6%
0.00%
Q3 2014$30,000
+275.0%
8,900
+178.1%
0.00%
Q2 2014$8,000
+60.0%
3,200
+33.3%
0.00%
Q1 2014$5,000
+150.0%
2,400
+140.0%
0.00%
Q4 2013$2,0001,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 40,300$283,0000.00%
SIMPLEX TRADING, LLC 4,500$31,0000.00%
JANE STREET GROUP, LLC 22,600$158,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders